FDA Releases Draft Guidelines to Minimize Transmission Risks of Hepatitis B, Hepatitis C, and HIV in Tissue Donations
January 07, 2025
January 07, 2025
WASHINGTON, Jan. 7 (TNSFR) -- The Food and Drug Administration (FDA) has announced the availability of three draft guidelines aimed at reducing the transmission risks of hepatitis B virus (HBV), hepatitis C virus (HCV), and human immunodeficiency virus (HIV) through human cells, tissues, and cellular and tissue-based products (HCT/Ps).
These guidelines update prior recommendations to help tissue donation establishments comply with donor eligibility requirements, which include scree . . .
These guidelines update prior recommendations to help tissue donation establishments comply with donor eligibility requirements, which include scree . . .